tiprankstipranks
Trending News
More News >
Mankind Pharma Ltd. (IN:MANKIND)
:MANKIND
India Market

Mankind Pharma Ltd. (MANKIND) Ratios

Compare
0 Followers

Mankind Pharma Ltd. Ratios

IN:MANKIND's free cash flow for Q4 2025 was ₹0.72. For the 2025 fiscal year, IN:MANKIND's free cash flow was decreased by ₹ and operating cash flow was ₹0.15. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio
2.24 3.10 2.32 1.68 2.89
Quick Ratio
1.53 2.37 1.50 1.01 2.01
Cash Ratio
0.18 0.18 0.16 0.12 0.12
Solvency Ratio
0.81 0.97 0.78 0.57 0.92
Operating Cash Flow Ratio
0.85 1.02 0.96 0.35 0.84
Short-Term Operating Cash Flow Coverage
15.00 12.58 12.79 1.12 6.43
Net Current Asset Value
₹ 8.67B₹ 41.81B₹ 22.61B₹ 15.75B₹ 23.97B
Leverage Ratios
Debt-to-Assets Ratio
0.03 0.02 0.02 0.10 0.04
Debt-to-Equity Ratio
0.04 0.02 0.02 0.14 0.05
Debt-to-Capital Ratio
0.04 0.02 0.02 0.12 0.05
Long-Term Debt-to-Capital Ratio
0.02 <0.01 <0.01 <0.01 0.01
Financial Leverage Ratio
1.46 1.28 1.31 1.49 1.35
Debt Service Coverage Ratio
12.44 11.77 9.05 1.86 7.23
Interest Coverage Ratio
69.05 142.90 36.38 34.48 86.28
Debt to Market Cap
<0.01 <0.01 <0.01 0.02 <0.01
Interest Debt Per Share
3.81 5.89 5.36 23.19 6.49
Net Debt to EBITDA
0.16 -0.06 -0.07 0.27 0.04
Profitability Margins
Gross Profit Margin
67.21%67.87%38.76%68.26%70.63%
EBIT Margin
24.58%23.33%19.45%25.45%27.32%
EBITDA Margin
26.27%27.18%23.18%27.59%29.23%
Operating Profit Margin
25.81%39.54%18.51%24.72%26.80%
Pretax Profit Margin
24.51%23.22%18.97%25.38%27.22%
Net Profit Margin
17.57%18.51%14.66%18.42%20.36%
Continuous Operations Profit Margin
18.01%18.79%14.98%18.67%20.81%
Net Income Per EBT
71.67%79.73%77.28%72.60%74.81%
EBT Per EBIT
94.97%58.71%102.52%102.67%101.57%
Return on Assets (ROA)
14.07%15.99%13.19%15.67%19.86%
Return on Equity (ROE)
20.49%20.43%17.24%23.29%26.80%
Return on Capital Employed (ROCE)
28.15%41.52%20.61%29.48%33.18%
Return on Invested Capital (ROIC)
18.21%33.01%15.83%19.27%24.49%
Return on Tangible Assets
14.24%18.61%16.15%19.76%19.98%
Earnings Yield
1.02%2.07%2.25%2.52%2.22%
Efficiency Ratios
Receivables Turnover
0.00 12.18 15.17 20.05 14.65
Payables Turnover
2.58 3.01 5.31 2.27 2.59
Inventory Turnover
2.14 2.14 3.50 1.40 1.54
Fixed Asset Turnover
3.15 3.29 2.84 3.26 3.12
Asset Turnover
1.16 0.86 0.90 0.85 0.98
Working Capital Turnover Ratio
4.62 2.99 4.12 3.59 3.02
Cash Conversion Cycle
70.11 79.47 59.56 117.70 120.44
Days of Sales Outstanding
16.14 29.96 24.06 18.21 24.92
Days of Inventory Outstanding
171.08 170.75 104.22 260.12 236.71
Days of Payables Outstanding
117.10 121.24 68.72 160.62 141.19
Operating Cycle
187.22 200.71 128.28 278.32 261.63
Cash Flow Ratios
Operating Cash Flow Per Share
26.70 53.73 44.55 22.96 28.39
Free Cash Flow Per Share
21.01 44.19 23.78 -35.59 20.59
CapEx Per Share
5.69 9.54 20.77 58.55 7.80
Free Cash Flow to Operating Cash Flow
0.79 0.82 0.53 -1.55 0.73
Dividend Paid and CapEx Coverage Ratio
1.81 5.63 2.14 0.39 3.64
Capital Expenditure Coverage Ratio
4.69 5.63 2.14 0.39 3.64
Operating Cash Flow Coverage Ratio
8.17 10.39 10.47 1.05 4.73
Operating Cash Flow to Sales Ratio
0.18 0.21 0.20 0.12 0.18
Free Cash Flow Yield
0.53%1.91%1.67%-2.50%1.45%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
55.29 48.41 44.45 39.75 45.02
Price-to-Sales (P/S) Ratio
9.71 8.96 6.52 7.32 9.17
Price-to-Book (P/B) Ratio
16.35 9.89 7.66 9.26 12.07
Price-to-Free Cash Flow (P/FCF) Ratio
67.69 52.32 59.82 -39.96 69.07
Price-to-Operating Cash Flow Ratio
53.26 43.03 31.93 61.95 50.10
Price-to-Earnings Growth (PEG) Ratio
0.71 0.98 -4.21 3.00 1.97
Price-to-Fair Value
16.35 9.89 7.66 9.26 12.07
Enterprise Value Multiple
36.91 32.90 28.05 26.80 31.40
Enterprise Value
571.37B 924.37B 568.41B 575.46B 570.49B
EV to EBITDA
61.07 32.90 28.05 26.80 31.40
EV to Sales
11.47 8.94 6.50 7.40 9.18
EV to Free Cash Flow
188.76 52.22 59.67 -40.36 69.16
EV to Operating Cash Flow
95.17 42.95 31.85 62.57 50.16
Tangible Book Value Per Share
90.50 197.03 146.54 110.38 120.41
Shareholders’ Equity Per Share
87.00 233.73 185.61 153.65 117.88
Tax and Other Ratios
Effective Tax Rate
0.27 0.19 0.22 0.26 0.24
Revenue Per Share
146.42 257.99 218.25 194.25 155.13
Net Income Per Share
25.72 47.75 32.00 35.78 31.59
Tax Burden
0.66 0.80 0.77 0.73 0.75
Interest Burden
1.01 1.00 0.98 1.00 1.00
Research & Development to Revenue
0.02 <0.01 0.02 0.03 0.03
SG&A to Revenue
0.22 0.22 0.13 0.02 0.01
Stock-Based Compensation to Revenue
0.00 <0.01 <0.01 0.00 0.00
Income Quality
1.04 1.13 1.39 0.47 0.67
Currency in INR
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis